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Abstract
Up-regulation of human endogenous retroviruses (HERVs) is associated with many diseases, including cancer. In
this study, an H family HERV (HERV-H)-related gene was identified and characterized. Its spliced transcript lacks
protein-coding capacity and may belong to the emerging class of noncoding RNAs (ncRNAs). The 1.3-kb RNA con-
sisting of four exons is transcribed from an Alu element upstream of a 5.0-kb structurally incomplete HERV-H ele-
ment. RT-PCR and quantitative RT-PCR results indicated that expression of this HERV-related transcript was
negatively associated with colon, stomach, and kidney cancers. Its expression was induced upon treatment with
DNA methylation and histone deacetylation inhibitors. A BLAT search using long terminal repeats (LTRs) identified
50 other LTR homogenous HERV-H elements. Further analysis of these elements revealed that all are structurally
incomplete and only five exert transcriptional activity. The results presented here recommend further investigation
into a potentially functional HERV-H-related ncRNA.
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Human endogenous retroviruses (HERVs) constitute
about 8% of the human genome and are distributed
throughout all chromosomes (Lander et al., 2001). H fam-
ily HERV (HERV-H) is one of the most abundant HERV
familiesinthehumangenome.Ithasrecentlybeenreported
that there are 926 pol-containing HERV-H pro-viruses in
the human genome (Jern et al., 2005). The pro-viral struc-
ture of HERVs mainly consists of 5’ LTR-gag-pro-pol-
env-3’ LTR, in which ‘LTR’ is the long terminal repeat,
and the four genes (gag: group-specific antigen, pro: prote-
ase, pol: polymerase, and env: envelope) encode struc-
tural/functional proteins essential for replication-com-
petent retroviruses. Though most HERV open reading
frames (ORFs) have been degraded by deletion or muta-
tion, HERV proteins and transcripts have been detected in
reproductive and cancerous cells, such as placenta (Blond
et al., 2000), teratocarcinoma cell lines (Lower et al.,
1993), breast tumor tissues (Wang-Johanning et al., 2003)
and cell lines (Faff et al., 1992), and germ cell tumors
(Herbst et al., 1996). In this study, a HERV-H-related gene
was identified and characterized. As opposed to what has
been described in the literature, this HERV-H-related gene
is down-regulated in cancers of the colon, stomach, and
kidney.
A 767-bp HERV-related sequence was amplified in
kidney samples with primers designed for RT-PCR detec-
tion of a gene we had previously been studying (forward:
5’CTCCTGcTCTTTGCTCCGTG3’, reverse:
5’GG_TTGTTCTCTGGtGGGCAG3’, lowercase for mis-
match and ‘_’ for lack). A BLAT search at the UCSC Ge-
nomeBrowserrevealedthatthesequenceconsistedofthree
exons with a genomic span of 4.3 kb on chromosome
4p15.2. Sequence analysis of the genomic sequence with
thetoolRepeatMaskerrevealeda5.0-kbHERV-Hprovirus
encompassing the 767-bp sequence. 3’ RACE assay re-
vealed this transcript to be polyadenylated at the expected
site within the 3’ LTR at a CA dinucleotide. 5’ RACE re-
sultsindicatedthattranscriptionofthisHERV-relatedtran-
script did not initiate within the expected 5’ LTR, but
withinanAluelementimmediatelyupstreamofthe5’LTR
(Figure 1A). Extensive sequence analysis of the 1.3-kb
full-length transcript revealed that it lacked protein-coding
capacity, thereby inferring that it might belong to the
emerging class of noncoding RNAs (ncRNAs). Nucleotide
sequences have already been deposited in GenBank with
accession numbers EF535612 (767-bp), EF535613 (3’ ter-
minus), and EU669866 (the full-length transcript).
The locus of the provirus was Chr4: 23333592-
23338589 (hg18) on the reverse strand. Flanked by 5-bp
CCCGC direct repeats at both ends and with intact LTRs,
the 5.0-kb HERV-H provirus had terminal structures corre-
sponding to integration into the genome through retro-
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Short Communicationtransposition. Pair-wise alignment of the 5.0-kb HERV-H
provirus with the 9.0-kb HERV-H consensus element con-
structed by Jern et al. (2005), was carried out with the tool,
GeneDoc. The alignment result was then shortened with
another tool, Visio, and edited by image editing software.
The regions were defined in the same way that Jern et al.
(2005) had defined the regions of the 9.0-kb HERV-H con-
sensus. Results showed that large fragments of the gag and
polregions,besidesnearlytheentireenvregion,weremiss-
ing in the 5.0-kb HERV-H provirus (Figure 1B). An addi-
tional 125-bp segment, lacking in the HERV-H consensus,
was found existing in the pre-gag region of 5.0-kb
HERV-H. A BLAT search with this 125-bp sequence re-
vealedthatsimilarsequenceswerecontainedinmanyother
HERV-H elements, hence suggesting that a HERV-H con-
sensus containing this segment would better represent an
‘original’ HERV-H provirus.
RT-PCR and quantitative RT-PCR (qRT-PCR) were
carried out in order to analyze the transcription level of the
HERV-H-related gene in tissue samples and cancer cell
lines. Tumor and adjacent normal tissues of the colon,
stomach, liver, lung, and kidney were obtained after surgi-
cal resection and stored frozen at -80 °C until RNA extrac-
tion(approvedbytheethicscommitteeofZhejiangUniver-
sity and with the formal consent of all the patients in-
volved). Cancer cells were grown in RPMI 1640
supplemented with 10% fetal calf serum. Total RNA was
prepared with Trizol reagent (Invitrogen), according to
manufacturer’s guidelines. RNA samples were always
treated with RQ1 RNase-free DNase (Promega) and puri-
fied with phenol/chloroform. RNA was then reverse-trans-
cribed into cDNA using M-MLV Reverse Transcriptase
(Promega). PCR assays were performed with Taq DNA
polymerase (Promega) in reaction systems containing
0.2 M forward and reverse primers each. Thermal cycler
parameterswere94°C5min,(94°C30s,58°C30s,72°C
40 s) x 30 cycles for -actin/36 for target gene, 72 °C
10min.SequencesoftheprimersarelistedinTable1.PCR
products were separated on a 1.5% agarose gel, purified
and directly sequenced.
RT-PCR results indicated that the HERV-H-related
transcript was expressed at relatively low levels in kidney
tumors when compared to adjacent normal tissues. Detec-
tion in colon and stomach samples also indicated that this
transcript was expressed at high levels in adjacent normal
tissues and at very low levels in tumor tissues (Figure 1C).
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Figure 1 - Structure and transcription of the HERV-H-related gene. (A) Schematic for structures of the HERV-related spliced transcript and its template
DNA. Thick bars represent exons and thin lines introns. DNA structure of this gene consists of an Alu element (gray) and a HERV provirus (white). Re-
gions of LTRs, pre-gag, gag, pro and pol in the HERV element are labeled. (B) Shortened pair-wise alignment, a result of the 5.0-kb HERV-H element at
4p15.2(E4)withtheHERV-Hconsensus(con).Blackindicatesregionsofhighhomogeneity.Graybarsinoneaccompaniedbydashlinesintheotherin-
dicate existing regions in the first and deletion in the other. Large segments from the gag, pol and env regions are absent in the HERV-H at 4p15.2,
whereas an additional 125-bp segment exists in the pre-gag region. (C) RT-PCR detection of the HERV-H4p15-related spliced transcript. The
HERV-H-related transcript was transcribed at higher levels in normal than tumor samples of the colon, stomach, and kidneys. (D) Quantitation of the
HERV-H4p15-related spliced transcript by qRT-PCR. The HERV-H-related transcript was significantly down-regulated in tumor samples from the co-
lon, stomach, and kidneys. The term ‘n’ indicates the number of samples. Expressional differences between tumor and normal samples were verified by t
tests. **p < 0.001, *p < 0.05. T: tumor; N: normal.Transcript levels were further analyzed by TaqMan qRT-
PCR, with the glyceraldehyde-3-phosphate dehydrogenase
gene (GAPDH) as the endogenous control gene and the av-
eragelevelofcolontumorsamplesasreference.Sequences
of the primers and probes are listed in Table 1. qRT-PCR
assays were performed in reaction systems containing
0.3Mofeachprimerand0.2Mofprobe.Thermalcycler
parametersofanABIPRISM7700sequencedetectionsys-
tem were 50 °C 2 min, 95 °C 10 min, (95 °C 15 s, 60 °C
1 min) x 40 cycles. qRT-PCR assays for detecting both
GAPDH and HERV-H4p15.2 were undertaken simulta-
neously at least three times. Data analysis was carried out
according to the Ct method (Livak and Schmittgen,
2001). Significant expressional differences were detected
between tumor and adjacent normal tissues of the three
types of cancers by paired-samples t tests with the
SPSS15.0 tool (Figure 1D). Expression of this transcript
was found in neither tumor nor normal tissues of both the
liver and lungs (results not shown).
RT-PCR results showed the HERV-H-related gene
was not transcribed in colon cancer cells HT29, SW480,
SW620 or LS 174T, and only at a low level in RKO (Figu-
re2A).Itwasexpressedatalowlevelintheembryonickid-
ney cell line 293T. No expression was detected in the
HepG2 liver cancer cell line, neither in placenta, which has
been reported to transcribe HERVs at high levels (Muir et
al., 2004). RT-PCR assays produced a smaller band in
RKO, SW620, LS 174T and 293T than has ever been seen
in tumor or normal tissue samples of the kidneys, colon,
stomach, liver or lungs. Sequencing results revealed that
this smaller band is another novel HERV-related spliced
transcript from 6q24.1 (GenBank accession number
EU791617).
Tumor down-regulation of this HERV-H-related
gene might be due to the use of an alien promoter rather
than the routine 5’ LTR. Genes affected by aberrant DNA
methylation and chromatin formation include over half of
thetumorsuppressorgenes(Baylinetal.,2001).Inorderto
determine whether the low to no expression of this tran-
script in cancer is regulated by DNA methylation, cancer
cells were treated with the DNA methylation inhibitor 5-
aza-2’-deoxycytidine (DAC; Sigma) and the histone dea-
cetylation inhibitor trichostatin A (TSA; Beyotime) as pre-
viously described (Cameron et al., 1999): initial treatment
with DAC (200 nM) for 48 h, with drug and medium re-
placement 24 h after beginning the treatment, followed by
that of the medium containing TSA (300 nM) for a further
24h.Cellswerealsotreatedwithhigh-dosageDAC(5M)
or 200 nM DAC only for 72 h, with drug and medium re-
placement every 24 h.
The target HERV-H-related transcript was expressed
at higher levels in HT29 through a combined DAC-and-
TSA treatment. Nevertheless, its expression did not in-
crease with either low or high doses of DAC alone, neither
was it expressed in SW480 nor SW620 with any type of
treatment. Expression of the other HERV-related transcript
(smaller band) was induced in HT29 and SW480 with all
the treatments. It was induced to a higher level in SW620
by DAC combined with TSA, but was in no way affected
by DAC alone (Figure 2B). The results presented herein in-
fer that the HERV-H4p15-related transcript might be regu-
lated by DNA methylation and histone deacetylation. The
other HERV-related transcript identified in various cancer
cell lines was regulated epigenetically. However, as it was
not transcribed in any type of tissue we tested, no further
studies were carried out.
BLAT searches with the 5’ and 3’ LTRs of HERV-
H4p15 identified a total of 50 HERV-H elements with
lengths ranging from 4690 bp to 6844 bp. Pair-wise align-
mentwasundertakenforeachofthe51elements(including
HERV-H4p15)withtheHERV-Hconsensus.Accordingto
the segment-deleting patterns, we classified the 51 ele-
ments into 10 groups (Supplementary Material, Figure S1).
Eightamongthesecontainedonlyonemembereach.Group
V contained three members, one of which was HERV-
H4p15. Group III contained the remaining 40 elements,
withlengthsrangingfrom5639to6142bp.Thedifferences
in length among members of group III were largely due to
part of the pre-gag region. Sequences in this part of the
pre-gag region differed greatly among all of the 51 HERV-
H elements. As this region is not viral-protein-associated,
lack of sequence conservation is not unexpected. So as to
simplify the classification of the 51 elements, this variable
part of the pre-gag region was not included.
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Figure 2 - Effects of DNA methylation and histone deacetylation inhibi-
tors on HERV-H4p15 transcription in cancer cells. (A) RT-PCR detection
of the HERV-H-related transcript in cancer cells and placenta. The tran-
script was expressed only in RKO and 293T, and, even then, at low levels
(568bp).Asmallerband(435bp)wasdetectedinRKO,SW620,LS174T
and293T,whichwasnotseenincolonsamples.M,marker;coT,colontu-
mor; coN, colon normal. (B) RT-PCR detection after treatment with DNA
methylation and histone deacetylation inhibitors. The target HERV-H-
related transcript was induced in HT29 after combination treatment with
DAC and TSA. The smaller band was induced in HT29 and SW480 with
all treatments. It was expressed at a higher level in SW620 after combina-
tion treatment with DAC and TSA, but was not affected by DAC only.
cDNA concentration was normalized by qRT-PCR detection of GAPDH
(not shown). M, marker; hD, high-dose DAC (5 M) for 72 h; D, DAC
(200 nM) for 72 h; DT, DAC (200 nM) for 48 h, followed by TSA
(300 nM) for a further 24 h; –, no drug control.Among the over one thousand members of H family
HERV, only 18 are relatively complete (Jern et al., 2005).
No viral particles produced by HERV-H have ever been
found. As shown in Figure S1, the six segments deleted in
the most abundant Group III are also correspondingly de-
leted in some of the other groups, thereby suggesting that
segment-deletion in HERV-H elements might be corre-
lated. This common deletion supports the proposal that
expansionofHfamilyHERVinthehumangenomeisasso-
ciated with copying mechanisms (Belshaw et al., 2005).
The 340-bp segment deleted in the group-specific antigen
region (gag), and commonly corresponding to nucleotide
1933 through 2272 in the HERV-H consensus, belongs to
the region encoding the Gag P30 core-shell protein, essen-
tial for viral assembly. The protease gene (pro) is not sub-
ject to deletion in any of the 51 elements, most likely due to
its short extension. The polymerase (pol), which contains
reversetranscriptase(RT),RNaseH,andintegrase(IN)do-
mains, has four sequence segments commonly deleted in
manyofthe51elements.Thefirstdeletedregioninpolcor-
responds to a 54-aa peptide containing a RT-ZFERV-like
conserved domain (a subfamily of RTs and found in se-
quencessimilartothoseoftheintactendogenousretrovirus
ZFERV from zebra-fish and Moloney murine leukemia vi-
rus). An RNase H conserved domain is contained in the
third deleted region in pol, whereas none is found in the
second and the fourth belongs to the IN coding region. The
envelope protein (env), which consists of the surface unit
(SU) and the transmembrane unit (TM), was proved to pos-
sess immunosuppressive properties (Mangeney et al.,
2001). It is almost entirely deleted in all but the sole mem-
ber of Group VIII.
Expression of the 51 HERV-H elements was
checked. According to results from the UCSC Genome
Browser on the Human Mar. 2006 Assembly, 14 of these
havesplicedexpressionsequencetags(ESTs).Onlyfiveel-
ements produce mRNA sequences, two of which are in-
cluded in designated genes. Thus, the results demonstrate
that most of these structurally incomplete HERV-H ele-
ments are inactive.
ncRNAisaglobaltermfortranscriptsthatlackanap-
parent ORF and do not encode a protein product. Some-
timesreferredtoasmRNA-likencRNAs,longncRNAsare
transcribedbyRNApolymeraseII,spliced,polyadenylated
and conceivably capped (Erdmann et al., 2000). There are
many examples of such long mRNA-like ncRNAs that as-
sume a role during development in both animals and plants
(Mattick, 2001). Sequence analysis revealed a lack of any
long ORF in the novel HERV-H-related transcript, thereby
implying that it might belong to the mRNA-like ncRNAs.
Contrarytowhathasbeendescribedintheliterature,inthis
study it was found that the HERV-H-related transcript was
down-regulated in cancers of the colon, stomach, and kid-
ney. Furthermore, and interestingly, the expression of this
HERV-H-related transcript can be induced upon treatment
with DNA methylation and histone deacetylation inhibi-
tors. Considering the abundance of HERV-H elements and
their variable expression pattern, a novel proposal is pre-
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Table 1 - Nucleotide sequences of the primers and probes used in this study
Usage/target Nucleotide sequence (5’ to 3’)/and matching target site
RT-PCR HERV-H 4p15.2 (568-bp) Forward: CCAATTTTAAATCAGGAGCTTGC (exon-exon boundary of exons 2 and 3)
Reverse: GGTGAGGCAGGGCATATTCA (exon 4)
-actin (control, 315-bp) Forward: TCCTGTGGCATCCACGAAACT
Reverse: GAAGCATTTGCGGTGGACGAT
qRT-PCR GAPDH (inner control) Forward: TCGACAGTCAGCCGCATCT
Reverse: CTTGACGGTGCCATGGAATT
Probe
i: FAM-CGTCGCCAGCCGAGCCACAT-TAMRA
HERV-H 4p15.2 Forward: TCCCCTGTCCTCCTGTTCTTT (exon 2)
Reverse: GAGTGGCTGCCAGGTGAGTT (exon 3)
Probe: FAM-TGCCCACAGCCCAGGGTTCCT-TAMRA (exon 3)
5’RACE
ii cDNA synthesis 5’phosphorylated-CCTGACATTCCTGCC
1
st round nested PCR Forward: GGGTAACTCTCACAGTGGAAGGTT
Reverse: TGGCTTGGTGGTCAGATTTCT
2
nd round nested PCR Forward: AGCCCTGAGAAACATCGCC
Reverse: AAGCTCCTGATTTAAAATTGGTGAG
3’RACE
iii Forward: CACAGTGGAGGAAGGCAGGAAT
iEach probe carried a 5’ reporter dye, 6-carboxyfluorescein (FAM) and a 3’ quencher dye, 6-carboxytetramethyl-rhodamine (TAMRA).
ii5’ RACE was
performed with the 5’ full RACE core set (Takara).
iii3’ RACE was performed with the 3’ RACE System (Invitrogen), other primers also being provided
with this kit.sented that some HERV-H-related RNAs function as regu-
lators to maintain HERV-H expression balance in a cell.
Additional studies on this newly identified HERV-H-
relatednon-codingsplicedtranscriptarewarrantedinorder
to elucidate its function.
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